Joseph T Crossno

Summary

Affiliation: University of Colorado Health Sciences Center
Country: USA

Publications

  1. ncbi request reprint Attenuation of hypoxia-induced pulmonary artery remodeling by a peroxisome proliferator-activated receptor-gamma agonist
    Joseph T Crossno
    Division of Pulmonary Sciences and Critical Care Medicine, Cardiovascular Pulmonary Laboratory, University of Colorado Health Sciences Center, Denver, CO 80262, USA
    Chest 128:580S. 2005
  2. ncbi request reprint Rosiglitazone attenuates hypoxia-induced pulmonary arterial remodeling
    Joseph T Crossno
    Pulmonary and Critical Care Services, Veterans Affairs Medical Center, Denver, USA
    Am J Physiol Lung Cell Mol Physiol 292:L885-97. 2007
  3. pmc Rosiglitazone promotes development of a novel adipocyte population from bone marrow-derived circulating progenitor cells
    Joseph T Crossno
    Research Section, Veterans Affairs Medical Center, Denver, CO, USA
    J Clin Invest 116:3220-8. 2006
  4. ncbi request reprint Depletion of cAMP-response element-binding protein/ATF1 inhibits adipogenic conversion of 3T3-L1 cells ectopically expressing CCAAT/enhancer-binding protein (C/EBP) alpha, C/EBP beta, or PPAR gamma 2
    Keith E Fox
    Research Service, Veterans Affairs Medical Center, University of Colorado Health Sciences Center, Denver, Colorado 80220, USA
    J Biol Chem 281:40341-53. 2006
  5. ncbi request reprint Hypoxia-induced pulmonary artery adventitial remodeling and neovascularization: contribution of progenitor cells
    Neil J Davie
    Developmental Lung Biology Group, UCHSC, 4200 East 9 th Ave, Rm 3419, Denver, CO 80262, USA
    Am J Physiol Lung Cell Mol Physiol 286:L668-78. 2004
  6. ncbi request reprint Antitumorigenic effect of Wnt 7a and Fzd 9 in non-small cell lung cancer cells is mediated through ERK-5-dependent activation of peroxisome proliferator-activated receptor gamma
    Robert A Winn
    Veterans Administration Medical Center, Denver, and Department of Medicine, University of Colorado Health Sciences Center, 80220, USA
    J Biol Chem 281:26943-50. 2006

Collaborators

Detail Information

Publications6

  1. ncbi request reprint Attenuation of hypoxia-induced pulmonary artery remodeling by a peroxisome proliferator-activated receptor-gamma agonist
    Joseph T Crossno
    Division of Pulmonary Sciences and Critical Care Medicine, Cardiovascular Pulmonary Laboratory, University of Colorado Health Sciences Center, Denver, CO 80262, USA
    Chest 128:580S. 2005
  2. ncbi request reprint Rosiglitazone attenuates hypoxia-induced pulmonary arterial remodeling
    Joseph T Crossno
    Pulmonary and Critical Care Services, Veterans Affairs Medical Center, Denver, USA
    Am J Physiol Lung Cell Mol Physiol 292:L885-97. 2007
    ..However, this agent fails to block the development of PH, apparently because of its inability to repress sustained Rho kinase-mediated arterial vasoconstriction...
  3. pmc Rosiglitazone promotes development of a novel adipocyte population from bone marrow-derived circulating progenitor cells
    Joseph T Crossno
    Research Section, Veterans Affairs Medical Center, Denver, CO, USA
    J Clin Invest 116:3220-8. 2006
    ..We conclude that TZDs and high-fat feeding promote the trafficking of BM-derived circulating progenitor cells to adipose tissue and their differentiation into ML adipocytes...
  4. ncbi request reprint Depletion of cAMP-response element-binding protein/ATF1 inhibits adipogenic conversion of 3T3-L1 cells ectopically expressing CCAAT/enhancer-binding protein (C/EBP) alpha, C/EBP beta, or PPAR gamma 2
    Keith E Fox
    Research Service, Veterans Affairs Medical Center, University of Colorado Health Sciences Center, Denver, Colorado 80220, USA
    J Biol Chem 281:40341-53. 2006
    ..The data also indicate that CREB not only functions during the initiation of adipogenic conversion but also at later stages...
  5. ncbi request reprint Hypoxia-induced pulmonary artery adventitial remodeling and neovascularization: contribution of progenitor cells
    Neil J Davie
    Developmental Lung Biology Group, UCHSC, 4200 East 9 th Ave, Rm 3419, Denver, CO 80262, USA
    Am J Physiol Lung Cell Mol Physiol 286:L668-78. 2004
    ..From these observations, we suggest that the vasa vasorum and circulating progenitor cells could be involved in vessel wall thickening in the setting of hypoxia-induced PH...
  6. ncbi request reprint Antitumorigenic effect of Wnt 7a and Fzd 9 in non-small cell lung cancer cells is mediated through ERK-5-dependent activation of peroxisome proliferator-activated receptor gamma
    Robert A Winn
    Veterans Administration Medical Center, Denver, and Department of Medicine, University of Colorado Health Sciences Center, 80220, USA
    J Biol Chem 281:26943-50. 2006
    ..These data suggest that ERK5-dependent activation of PPARgamma represents a major effector pathway mediating the anti-tumorigenic effects of Wnt 7a and Fzd 9 in NSCLC...